Paper40607289
Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.
Shiratori F and 16 others. Ann Gastroenterol Surg, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study. Papers, record 40607289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40607289
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30003189 | p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma. | Ann Gastroenterol Surg | 2018 | https://conductscience.org/library/papers/30003189 | PubMed |
| 2 | 33363728 | Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer. | Mol Clin Oncol | 2021 | https://conductscience.org/library/papers/33363728 | PubMed |
| 3 | 35429246 | Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy. | Cancer Immunol Immunother | 2022 | https://conductscience.org/library/papers/35429246 | PubMed |
| 4 | 17855703 | The impact of autoimmune diseases on the incidence and prognosis of cutaneous malignant melanoma. | Cancer Epidemiol Biomarkers Prev | 2007 | https://conductscience.org/library/papers/17855703 | PubMed |
| 5 | 34632560 | Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers. | Int J Clin Oncol | 2022 | https://conductscience.org/library/papers/34632560 | PubMed |
| 6 | 40607289 | Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study. | Ann Gastroenterol Surg | 2025 | https://conductscience.org/library/papers/40607289 | PubMed |
| 7 | 30950146 | Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30950146 | PubMed |
| 8 | 31535225 | Recent progress in multidisciplinary treatment for patients with esophageal cancer. | Surg Today | 2020 | https://conductscience.org/library/papers/31535225 | PubMed |
| 9 | 28064445 | Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer. | Cancer Sci | 2017 | https://conductscience.org/library/papers/28064445 | PubMed |
| 10 | 32458231 | Serum p53 antibody: useful for detecting gastric cancer but not for predicting prognosis after surgery. | Surg Today | 2020 | https://conductscience.org/library/papers/32458231 | PubMed |
| 11 | 27110229 | Comprehensive Registry of Esophageal Cancer in Japan, 2009. | Esophagus | 2016 | https://conductscience.org/library/papers/27110229 | PubMed |
| 12 | 11042560 | Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. | Cancer | 2000 | https://conductscience.org/library/papers/11042560 | PubMed |
| 13 | 15383868 | Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. | World J Surg | 2004 | https://conductscience.org/library/papers/15383868 | PubMed |
| 14 | 29691673 | Multi-panel assay of serum autoantibodies in colorectal cancer. | Int J Clin Oncol | 2018 | https://conductscience.org/library/papers/29691673 | PubMed |
| 15 | 25906289 | NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers. | J Gastroenterol | 2016 | https://conductscience.org/library/papers/25906289 | PubMed |
| 16 | 32490341 | Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancers. | Ann Gastroenterol Surg | 2020 | https://conductscience.org/library/papers/32490341 | PubMed |
| 17 | 30150518 | A Multicenter Study to Assess EGFR Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30150518 | PubMed |
| 18 | 27553002 | A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer. | Cancer Immunol Immunother | 2016 | https://conductscience.org/library/papers/27553002 | PubMed |
| 19 | 32574375 | Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study. | Int J Cancer | 2020 | https://conductscience.org/library/papers/32574375 | PubMed |
| 20 | 23208313 | Investigation of the freely available easy-to-use software 'EZR' for medical statistics. | Bone Marrow Transplant | 2013 | https://conductscience.org/library/papers/23208313 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42220520 | Tumor antigen-associated autoantibodies: generation mechanisms, roles in tumorigenesis and progression, and clinical application prospects. | Front Immunol | 2026 | https://conductscience.org/library/papers/42220520 | PubMed |
| 41971943 | Computational Approach Improves Diagnostic Performance Based on Tumor-Associated Autoantibodies in Esophageal Squamous Cell Carcinoma. | Comput Struct Biotechnol J | 2026 | https://conductscience.org/library/papers/41971943 | PubMed |
| 40607289 | Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study. | Ann Gastroenterol Surg | 2025 | https://conductscience.org/library/papers/40607289 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTAG1A | 246100 | PubTator's text mining | https://conductscience.org/library/genes/246100 | NCBI Gene |
| EIF1 | 10209 | PubTator's text mining | https://conductscience.org/library/genes/10209 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| NUP62 | 23636 | PubTator's text mining | https://conductscience.org/library/genes/23636 | NCBI Gene |
| RALA | 5898 | PubTator's text mining | https://conductscience.org/library/genes/5898 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40607289
GET https://conductscience.org/api/papers/v1/40607289/references?page=2